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Introduction: Breast sentinel lymph node biopsy (SLNB) evaluates if cancer has spread outside the breast, by allowing 
the identification of the node that has the highest probability of harboring metastastis. Once it is identified and removed 
during surgery, histologic examination looks for the presence of metastasis. If metastasis are identified, the patient will 
have an axillary dissection performed, if no metastasis are identified, the patient can spare the axillary dissection with 
its associated morbility. SLNB procedures are performed with radiotracers or with dyes, or a combination of both. 
Recently, the hybrid tracer (fluorescent-radioactive) 99mTc nanocolloid indocyanine green (99mTc NC ICG) has been 
described. The aim of our work is to describe our experience with the hybrid tracer in breast SLN biopsy. Materials 
Patients were inyected periareolary subcutaneous in the same cuadrant of the lesions. Planar Scintigraphic and 
SPECT/CT (Mediso Anyscan) images were later acquired. During the SLNB a gamma probe (Europrobe) and our own 
developed near infrared (NIR) visualization system was used to localize the SLN. This combination allowed surgeons 
to guide them to the SLN using the acoustic cue provided from the gamma probe and the images from the NIR 
visualization system. Once the nodes were found they were removed and examined histopathologically. Patients who 
had positive SLNB underwent axillary dissection. 
Results: SLNB with 99mTc NC ICG allowed us to use their complementary fluorescent and radioactive properties in 
order to find the SLN. In this way, the gamma probe guided us to the region where the node was, and fluorescence made 
it easy to remove it and spare the rest of surrounding tissue. In this way we could remove 38 nodes, being 4 positive. 
All radioactive nodes where fluorescent. 
Conclusions: SLNB with 99mTc NC ICG could be performed without complications, having no adverse effects on 
patients. The hybrid tracer adds a visual cue with to the procedure aiding surgeons on SLN localization and removal. 
 
